News 16.09.2021 SCHLIEREN, ZURICH, September 16, 2021 — Anjarium Biosciences AG (“Anjarium”), a biotech company focused on creating and delivering a new class of non-viral gene therapies today announced the closing of a CHF55.5M ($61M) Series A financing. The round was co-led by Abingworth and Gimv, with significant participation from Omega Funds,...
News 09.09.2021 Schlieren (Zurich), Switzerland, 9 September, 2021 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for MagnetOs Easypack Putty, a soft and moldable formulation ideal for packing into...
Events, Internal events
Event date: 21.09.2021
Gastronomie Wagi-S at Wagistrasse 12
Discover how CSEM can support Life Sciences companies to innovate
Innovation in the field of Life Sciences increasingly requires multi-disciplinary competences – at the convergence between technology and biology. CSEM’s technology platforms address the evolving needs of the life science domain by utilizing the latest advancements in...
Events, External events
Event date: 07.09.2021
We would like to invite you to a virtual event on state-of-the-art developments in immune cell engagers in hematological malignancies on Tuesday 7th September (15:00 – 18:00 CEST), hosted by Johnson & Johnson Innovation, in collaboration with Janssen Oncology Research & Development. This event will bring together entrepreneurs, start-ups, and...
Events, External events
Event date: 25.08.2021
Das erwartet Sie.
Im feierlichen Rahmen prämieren wir an diesem Abend ein Jungunternehmen, welches ein herausragendes technisches Projekt entwickelt hat. Ein Projekt, das sich durch besondere Innovationskraft, Marktnähe und soziale Relevanz auszeichnet.
Die Auszeichnung steht für den Pioniergeist der Gründer sowie für die mathematische Konstante Pi als Symbol für Wissenschaft und Technik....